PAIM
NVS icon

Punch & Associates Investment Management’s Novartis NVS Stock Holding History

Punch & Associates Investment Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-33,901
Closed -$2.46M – 208
2018
Q1 		$2.46M Sell
33,901
-967
-3% -$73.6K 0.22% 151
2017
Q4 		$2.62M Sell
34,868
-403
-1% -$30.4K 0.23% 147
2017
Q3 		$2.71M Sell
35,271
-236
-0.7% -$17.8K 0.24% 143
2017
Q2 		$2.66M Sell
35,507
-584
-2% -$41.4K 0.25% 146
2017
Q1 		$2.4M Buy
36,091
+263
+0.7% +$17.5K 0.23% 148
2016
Q4 		$2.34M Buy
35,828
+54
+0.2% +$3.5K 0.23% 146
2016
Q3 		$2.53M Buy
35,774
+531
+2% +$38.7K 0.27% 134
2016
Q2 		$2.61M Buy
35,243
+574
+2% +$39.7K 0.3% 126
2016
Q1 		$2.25M Sell
34,669
-1,254
-3% -$85.3K 0.27% 132
2015
Q4 		$2.77M Buy
35,923
+4,534
+14% +$360K 0.33% 118
2015
Q3 		$2.58M Buy
31,389
+628
+2% +$55.9K 0.35% 119
2015
Q2 		$2.71M Buy
30,761
+479
+2% +$43.9K 0.34% 121
2015
Q1 		$2.68M Sell
30,282
-2,124
-7% -$188K 0.33% 120
2014
Q4 		$2.69M Sell
32,406
-206
-0.6% -$17.1K 0.35% 119
2014
Q3 		$2.75M Sell
32,612
-139
-0.4% -$11.2K 0.38% 118
2014
Q2 		$2.66M Buy
32,751
+331
+1% +$26K 0.36% 121
2014
Q1 		$2.47M Sell
32,420
-342
-1% -$24.9K 0.34% 125
2013
Q4 		$2.36M Sell
32,762
-534
-2% -$37.1K 0.32% 130
2013
Q3 		$2.29M Sell
33,296
-567
-2% -$37.5K 0.36% 128
2013
Q2 		$2.15M Buy
+33,863
New +$2.2M 0.38% 127

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Punch & Associates Investment Management's NVS Position: Q2 2018 in Review

Punch & Associates Investment Management sold out of Novartis (NVS) in Q2 2018, closing a stake of 33,901 shares — an estimated $2.46M sold.

Punch & Associates Investment Management first reported a position in NVS in Q2 2013 and held it in 20 quarters. The position peaked at $2.77M in Q4 2015. 988 funds tracked by Wall St. Rank hold NVS as of Q2 2018.

  • Punch & Associates Investment Management reported no remaining Novartis position as of Q2 2018 after selling out during the quarter.
  • Punch & Associates Investment Management sold 33,901 Novartis shares in Q2 2018, an estimated $2.46M.
  • Punch & Associates Investment Management first reported a position in Novartis in Q2 2013 and held it in 20 quarters.
  • Punch & Associates Investment Management's Novartis position peaked at $2.77M in Q4 2015.
  • 988 funds tracked by Wall St. Rank held Novartis as of Q2 2018.

Based on Punch & Associates Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.